Ross Macdonald Email and Phone Number
Ross Macdonald work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Ross Macdonald personal email
A successful senior pharmaceutical executive with over thirty years’ local and international experience in unit and general management in the industry. Possesses outstanding business instincts and has a proven record of achievement and leadership. Notably has bought products from lab bench to market, including being directly involved in the development and/or commercialisation of over 15 pharmaceutical products, providing a stellar financial return. Broad-based experience in capital raising, profit centre management, technology commercialisation, strategic planning, deal negotiation and transaction (licensing, M&A, asset sale & purchase), market and industry analysis, human resource management, product development and finance. Comfortable in different cultures with hands-on business experience in Asia, Europe, USA and Australia. Possesses formal biomedical and business qualifications.
-
Chief Commercial Officer (Cco)Stemsight - Vision Unlimited Nov 2023 - PresentTampere, Fi
-
Non Executive DirectorTrioda Wilingi Pty Ltd Jun 2023 - PresentTrioda Wilingi is majority owned by Indigenous Australians and will develop and commercialise innovative medical gels from cellulose nanofibres extracted from spinifex grass harvested in north-west Queensland. Trioda Wilingi has exclusive global rights to develop novel injectable spinifex-derived medical gels, which have many potential applications including osteoarthritis, drug delivery and dermo-cosmetic treatments.
-
Chief Executive Officer And Managing DirectorCynata Therapeutics Aug 2013 - Jun 2023Cremorne, Victoria, AuCynata Therapeutics Ltd (ASX: CYP) is an Australian stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology, Cymerus™, originating from the University of Wisconsin-Madison, a world leader in stem cell research. The proprietary Cymerus™ technology seeks to address a critical shortcoming in existing methods of production of mesenchymal stem cells (MSCs) for therapeutic use, which is the ability to achieve economic manufacture at commercial scale. Cymerus™ does so through the production of a particular type of MSC precursor, called a mesenchymoangioblast (MCA). The Cymerus™ MCA platform provides a source of MSCs that is independent of donor limitations and provides a potential “off-the-shelf” stem cell platform for therapeutic product use, with a pharmaceutical business model and economies of scale. This has the potential to create a new standard in the emergent arena of stem cell therapeutics and provides both a unique differentiator and an important competitive position. -
Non-Executive DirectorIsonea Limited Apr 2012 - Feb 2014iSonea Ltd (ASX:ISN; OTCQX: ISOAY) is an emerging medical technology company developing innovative, non-invasive devices and mobile health apps to improve the treatment of chronic respiratory disorders such as asthma and COPD.
-
Non-Executive DirectorHatchtech Pty Ltd Jan 2010 - Nov 2013Camberwell, Victoria, Au -
Chief Executive OfficerHatchtech Pty Ltd Apr 2012 - Mar 2013Camberwell, Victoria, AuHatchtech Pty Ltd is a venture-funded, specialty pharmaceutical company based in Melbourne, Australia developing proprietary technology for the control of head lice. The Company’s lead product is Xeglyze (fka DeOvo™), a proprietary, next generation topical head lice treatment. Xeglyze is a new chemical entity with a novel mode of action and potent inhibitory activity against lice and their eggs. During my period at the Company the product successfully completed Phase 2b clinical trials in the US and undertook a $6m financing in late 2012. Phase 3 has now been completed, with the expectation of FDA approval for launch in the US prescription market in 2016-17.
-
Non Executive DirectorTelesso Technologies Ltd 2003 - Nov 2013
-
Managing Director & CeoLiving Cell Technologies Limited Aug 2010 - Jun 2011Managing Director and Chief Executive Officer of Living Cell Technologies Ltd. LCT is an Australian stock-exchange listed, New Zealand based biotechnology company focused on developing living cell products for the treatment of diabetes, neurological disease and haemophilia. LCT is internationally recognised for its research and development of therapies in disease areas that typically have no cure or poor treatment options. Our most advanced therapy, DIABECELL® for Type 1 diabetes is in Phase II trials.LCT is focused on building a successful cell-based therapeutics business and in 2007, established itself as the only xenoimplantation (animal to human implantation) company to have achieved clinical trial status under the current regulatory environment. LCT is now poised to take its products through the clinical trials process, and to market.
-
Vice President, Business DevelopmentSinclair Pharmaceuticals Ltd Nov 2008 - Dec 2009London, Gb -
Vice President, Corporate DevelopmentStiefel Laboratories Jun 2007 - Apr 2008Rtp, Nc, Us -
Vice President Business DevelopmentConnetics Oct 2001 - Jan 2007Rtp, Nc, Us
-
Bio Committee MemberAusindustry Industry Research And Development Board 2001 - 2007
-
Vice President, Research & DevelopmentF.H. Faulding And Co Limited 2000 - 2001
-
Managing DirectorSoltec Research Pty Ltd (F.H. Faulding Ltd) 1996 - 2001
-
Business Development ManagerAmrad Corporation 1993 - 1996
Ross Macdonald Skills
Ross Macdonald Education Details
-
Monash UniversityBiochemistry; Business Admin -
Caulfield Grammar SchoolHigher School Certificate
Frequently Asked Questions about Ross Macdonald
What company does Ross Macdonald work for?
Ross Macdonald works for Stemsight - Vision Unlimited
What is Ross Macdonald's role at the current company?
Ross Macdonald's current role is Chief Commercial Officer at StemSight.
What is Ross Macdonald's email address?
Ross Macdonald's email address is rm****@****.net.au
What schools did Ross Macdonald attend?
Ross Macdonald attended Monash University, Caulfield Grammar School.
What skills is Ross Macdonald known for?
Ross Macdonald has skills like Biotechnology, Commercialization, Pharmaceutical Industry, Technology Transfer, Licensing, Clinical Trials, Mergers And Acquisitions, Medical Devices, Life Sciences, Strategic Planning, Fda, Biopharmaceuticals.
Free Chrome Extension
Find emails, phones & company data instantly
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial